Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/101285
Title: NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery : a prospective observational study
Author(s): Elitok, SabanLook up in the Integrated Authority File of the German National Library
Devarajan, Prasad
Bellomo, RinaldoLook up in the Integrated Authority File of the German National Library
Isermann, BerendLook up in the Integrated Authority File of the German National Library
Haase, MichaelLook up in the Integrated Authority File of the German National Library
Haase-Fielitz, AnjaLook up in the Integrated Authority File of the German National Library
Issue Date: 2022
Type: Article
Language: English
URN: urn:nbn:de:gbv:ma9:1-1981185920-1032406
Subjects: Cardiopulmonary bypass
Cardiorenal syndrome
NGAL/hepcidin-25 ratio
Subclinical AKI
Abstract: Background Acute kidney injury (AKI) subtypes combining kidney functional parameters and injury biomarkers may have prognostic value. We aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL)/hepcidin-25 ratio (urinary concentrations of NGAL divided by that of hepcidin-25) defined subtypes are of prognostic relevance in cardiac surgery patients. Methods We studied 198 higher-risk cardiac surgery patients. We allocated patients to four groups: Kidney Disease Improving Global Outcomes (KDIGO)-AKI-negative and NGAL/hepcidin-25 ratio-negative (no AKI), KDIGO AKI-negative and NGAL/hepcidin-25 ratio-positive (subclinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-negative (clinical AKI), KDIGO AKI-positive and NGAL/hepcidin-25 ratio-positive (combined AKI). Outcomes included in-hospital mortality (primary) and long-term mortality (secondary). Results We identified 127 (61.6%) patients with no AKI, 13 (6.6%) with subclinical, 40 (20.2%) with clinical and 18 (9.1%) with combined AKI. Subclinical AKI patients had a 23-fold greater in-hospital mortality than no AKI patients. For combined AKI vs. no AKI or clinical AKI, findings were stronger (odds ratios (ORs): 126 and 39, respectively). After adjusting for EuroScore, volume of intraoperative packed red blood cells, and aortic cross-clamp time, subclinical and combined AKI remained associated with greater in-hospital mortality than no AKI and clinical AKI (adjusted ORs: 28.118, 95% CI 1.465–539.703; 3.737, 95% CI 1.746–7.998). Cox proportional hazard models found a significant association of biomarker-informed AKI subtypes with long-term survival compared with no AKI (adjusted ORs: pooled subclinical and clinical AKI: 1.885, 95% CI 1.003–3.542; combined AKI: 1.792, 95% CI 1.367–2.350). Conclusions In the presence or absence of KDIGO clinical criteria for AKI, the urinary NGAL/hepcidin-25-ratio appears to detect prognostically relevant AKI subtypes.
URI: https://opendata.uni-halle.de//handle/1981185920/103240
http://dx.doi.org/10.25673/101285
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Sponsor/Funder: Projekt DEAL 2021
Journal Title: Journal of nephrology
Publisher: Springer
Publisher Place: Milano
Volume: 35
Issue: 2
Original Publication: 10.1007/s40620-021-01063-5
Page Start: 597
Page End: 605
Appears in Collections:Medizinische Fakultät (OA)

Files in This Item:
File Description SizeFormat 
Elitok et al._NGAL-hepcidin-25_2022.pdfZweitveröffentlichung1.81 MBAdobe PDFThumbnail
View/Open